How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Behring Diagnostics, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
145 clearance records and 0 recall records in the covered releases, across 1 source company names and 80 product codes. Dated history runs from Dec 30, 1976 to Oct 27, 1997.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| NEOTHROMITIN(R)K924395 · GPO | Behring Diagnostics, Inc. | 510(k) | Dec 1, 1992FDA decision date |
| CLIBRATION PLASMASK924404 · GGN | Behring Diagnostics, Inc. | 510(k) | Dec 1, 1992FDA decision date |
| CONTROL PLASMA PK924405 · GGC | Behring Diagnostics, Inc. | 510(k) | Dec 1, 1992FDA decision date |
| ENZYGNOST F 1+2K922934 · MIF | Behring Diagnostics, Inc. | 510(k) | Nov 16, 1992FDA decision date |
| STANDARD HUMAN PLASMAK924393 · JPA | Behring Diagnostics, Inc. | 510(k) | Nov 16, 1992FDA decision date |
| ENZYGNOST(R) TOXOPLASMOSIS/IGGK913731 · LGD | Behring Diagnostics, Inc. | 510(k) | Apr 29, 1992FDA decision date |
| ENZYGNOST(R) ANTI-CMV IGGK913910 · LFZ | Behring Diagnostics, Inc. | 510(k) | Apr 28, 1992FDA decision date |
| SUPPLEMENTARY REAGENTS FOR ENZYGNOST/TMBK920416 · LIB | Behring Diagnostics, Inc. | 510(k) | Apr 8, 1992FDA decision date |
| ENZYGNOST TOXOPLASMOSIS/IGMK913505 · LGD | Behring Diagnostics, Inc. | 510(k) | Mar 4, 1992FDA decision date |
| TURBIQUANTK920124 · DHR | Behring Diagnostics, Inc. | 510(k) | Mar 2, 1992FDA decision date |
| ENZYGNOST(R) ANTI-CMV/IGMK913693 · LFZ | Behring Diagnostics, Inc. | 510(k) | Feb 27, 1992FDA decision date |
| N/T PROTEIN CONTROL UYK914890 · JJY | Behring Diagnostics, Inc. | 510(k) | Feb 6, 1992FDA decision date |
| ENZYGNOST ANTI-CMV/IGG + IGMK901485 · LFZ | Behring Diagnostics, Inc. | 510(k) | May 20, 1991FDA decision date |
| NA ALPHA 1 MICROGLOBULIN KITK904254 · JZG | Behring Diagnostics, Inc. | 510(k) | Apr 5, 1991FDA decision date |
| RAPITEX(R) ASL NEWK903854 · GTQ | Behring Diagnostics, Inc. | 510(k) | Jan 28, 1991FDA decision date |
| TURBIQUANT MYOGLOBINK905202 · DDR | Behring Diagnostics, Inc. | 510(k) | Dec 13, 1990FDA decision date |
| TURBIQUANT MYOGLOBINK903687 · DDR | Behring Diagnostics, Inc. | 510(k) | Oct 16, 1990FDA decision date |
| RAPITEX(R) RF NEWK903852 · DHR | Behring Diagnostics, Inc. | 510(k) | Aug 30, 1990FDA decision date |
| RAPITEX (R) CRP NEWK903853 · DCN | Behring Diagnostics, Inc. | 510(k) | Aug 30, 1990FDA decision date |
| BEHRING CHROMOTIMERK901829 · JJQ | Behring Diagnostics, Inc. | 510(k) | Jul 24, 1990FDA decision date |
| BEHRING LASER NEPHELOMETERK761234 · JZW | Behring Diagnostics, Inc. | 510(k) | Jun 7, 1990FDA decision date |
| NA LATEX MYOGLOBIN TESTK902154 · DDR | Behring Diagnostics, Inc. | 510(k) | Jun 1, 1990FDA decision date |
| CELLOGNOST SYPHILIS HK896410 · GMT | Behring Diagnostics, Inc. | 510(k) | May 15, 1990FDA decision date |
| TURBIQUANT IMMUNOGLOBULIN & ALBUMIN KITK900167 · DCF | Behring Diagnostics, Inc. | 510(k) | Jan 22, 1990FDA decision date |
| BEHRING NEPHELOMETER 100K892223 · JZW | Behring Diagnostics, Inc. | 510(k) | May 4, 1989FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.